Evidence map›Paper›PMID 35148383›Full record

ArticleBrain : a journal of neurology2022

DNAJC30 defect: a frequent cause of recessive Leber hereditary optic neuropathy and Leigh syndrome.

Sarah L Stenton, Marketa Tesarova, Natalia L Sheremet, Claudia B Catarino, Valerio Carelli, Elżbieta Ciara, Kathryn Curry, Martin Engvall, Leah R Fleming, Peter Freisinger and 15 more

Open access · hybridAbstract read
In one paragraph

Article in Brain : a journal of neurology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
3.4field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 42 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. RNA Sequencing Resolves Cryptic Pathogenic Variants in Mitochondrial Disease.Annals of clinical and translational neurology · 2026
    Article
  5. Functions of J-domain proteins in mitochondrial protein biogenesis.Protein science : a publication of the Protein Society · 2026
    Review
  6. Article
  7. Article
  8. Article
  9. Leber's hereditary optic neuropathy - current status of idebenone and gene replacement therapies.Medizinische Genetik : Mitteilungsblatt des Berufsverbandes Medizinische Genetik e.V · 2025
    Article
  10. Autosomal Recessive Leber Hereditary Optic Neuropathy Triggered by Superior Mesenteric Artery Syndrome.Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society · 2025
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. RecessiveJournal of medical genetics · 2023
    Article
  17. International journal of molecular sciences · 2023
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

25 authors at 12 institutions in 7 countries.

Sarah L StentonInstitute of Human Genetics, School of Medicine, Technische Universität München, München, Germany.
Marketa TesarovaDepartment of Pediatrics and Inherited Metabolic Disorders, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic.
Natalia L SheremetFederal State Budgetary Institution of Science 'Research Institute of Eye Diseases', Moscow, Russia.
Claudia B CatarinoDepartment of Neurology, Friedrich-Baur-Institute, University Hospital of the Ludwig-Maximilians-Universität München, Munich, Germany.
Valerio CarelliIRCCS Istituto delle Scienze Neurologiche di Bologna, Programma di Neurogentica, Bologna, Italy.
Elżbieta CiaraDepartment of Medical Genetics, The Children's Memorial Health Institute, Warsaw, Poland.
Kathryn CurryGenetics and Metabolic Clinic, St. Luke's Health System, Boise, USA.
Martin EngvallCentre for Inherited Metabolic Diseases (CMMS), Karolinska University Hospital, Stockholm, Sweden.
Leah R FlemingGenetics and Metabolic Clinic, St. Luke's Health System, Boise, USA.
Peter FreisingerDepartment of Paediatrics, Metabolic Disease Center, Klinikum Reutlingen, Reutlingen, Germany.
Katarzyna Iwanicka-PronickaDepartment of Medical Genetics, The Children's Memorial Health Institute, Warsaw, Poland.
Elżbieta JurkiewiczDepartment of Diagnostic Imaging, The Children's Memorial Health Institute, Warsaw, Poland.
Thomas KlopstockDepartment of Neurology, Friedrich-Baur-Institute, University Hospital of the Ludwig-Maximilians-Universität München, Munich, Germany.
Mary K KoenigCenter for the Treatment of Pediatric Neurodegenerative Disease, The University of Texas McGovern Medical School at Houston, Houston, USA.
Hana KolářováDepartment of Pediatrics and Inherited Metabolic Disorders, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic.
Bohdan KousalDepartment of Ophthalmology, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic.
Tatiana KrylovaResearch Centre for Medical Genetics, Moscow, Russia.
Chiara La MorgiaIRCCS Istituto delle Scienze Neurologiche di Bologna, Programma di Neurogentica, Bologna, Italy.
Lenka NoskováDepartment of Pediatrics and Inherited Metabolic Disorders, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic.
Dorota Piekutowska-AbramczukDepartment of Medical Genetics, The Children's Memorial Health Institute, Warsaw, Poland.
Sam N RussoCenter for the Treatment of Pediatric Neurodegenerative Disease, The University of Texas McGovern Medical School at Houston, Houston, USA.
Viktor StráneckýDepartment of Pediatrics and Inherited Metabolic Disorders, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic.
Iveta TóthováDepartment of Pediatrics and Inherited Metabolic Disorders, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic.
Frank TräiskDepartment of Neuro-Ophthalmology, St Erik Eye Hospital, Stockholm, Sweden.
Holger ProkischInstitute of Human Genetics, School of Medicine, Technische Universität München, München, Germany.ORCID 0000-0003-2379-6286
Charles University · CZChildren's Memorial Health Institute · PLHelmholtz Zentrum München · DEIstituto delle Scienze Neurologiche di Bologna · ITSaint Luke's Health System · USFederal State Scientific Institution Research Institute of Eye Diseases · RUGerman Center for Neurodegenerative Diseases · DEKarolinska University Hospital · SEKreiskliniken Reutlingen · DELudwig-Maximilians-Universität München · DEResearch Centre for Medical Genetics · RUS:t Eriks Ögonsjukhus · SE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The recent description of biallelic DNAJC30 variants in Leber hereditary optic neuropathy (LHON) and Leigh syndrome challenged the longstanding assumption for LHON to be exclusively maternally inherited and broadened the genetic spectrum of Leigh syndrome, the most frequent paediatric mitochondrial disease. Herein, we characterize 28 so far unreported individuals from 26 families carrying a homozygous DNAJC30 p.Tyr51Cys founder variant, 24 manifesting with LHON, two manifesting with Leigh syndrome, and two remaining asymptomatic. This collection of unreported variant carriers confirms sex-dependent incomplete penetrance of the homozygous variant given a significant male predominance of disease and the report of asymptomatic homozygous variant carriers. The autosomal recessive LHON patients demonstrate an earlier age of disease onset and a higher rate of idebenone-treated and spontaneous recovery of vision in comparison to reported figures for maternally inherited disease. Moreover, the report of two additional patients with childhood- or adult-onset Leigh syndrome further evidences the association of DNAJC30 with Leigh syndrome, previously only reported in a single childhood-onset case.

Indexed as

Leigh DiseaseOptic Atrophy, Hereditary, LeberAdultChildDNA, MitochondrialFemaleHumansMaleMutationOptic Atrophies, HereditaryDNA, MitochondrialDNAJC30Leigh syndromeLHONmitochondrial disease

Identifiers

PMID35148383
PMCPMC9166554
OpenAlexW4210822947

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.